key: cord-0760265-etq9hh7f authors: Cardona‐Ospina, Jaime A.; Arteaga‐Livias, Kovy; Villamil‐Gómez, Wilmer E.; Pérez‐Díaz, Carlos E.; Katterine Bonilla‐Aldana, D.; Mondragon‐Cardona, Álvaro; Solarte, Marco; Martinez, Ernesto; Millan‐Oñate, Jose; López, Eduardo; López, Pio; Navarro, Juan‐Carlos; Perez‐Garcia, Luis; Mogollon‐Rodriguez, Euler; Rodríguez‐Morales, Alfonso J.; Paniz‐Mondolfi, Alberto title: Dengue and COVID‐19, overlapping epidemics? An Analysis from Colombia date: 2020-06-19 journal: J Med Virol DOI: 10.1002/jmv.26194 sha: 03c984829b6472648bf72dba64e03a17b907a2ec doc_id: 760265 cord_uid: etq9hh7f Coronavirus Disease 2019 (COVID‐19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2), has rapidly spread throughout Latin America, a region swept by multiple previous and ongoing epidemics. There are significant concerns that the arrival of COVID‐19 is currently overlapping with other viruses, particularly dengue, in various endo‐epidemic regions across South America. In this report, we analyzed trends for both viral infections in Colombia during the first 20 epidemiological weeks of 2020. From January 1st to May 16th, 2020 (epidemiological weeks, EW, 1‐20), a total of 52,679 cases of dengue and 14,943 cases of COVID‐19 have been confirmed in Colombia. As both conditions may potentially lead to fatal outcomes, especially in patients with chronic co‐morbidities, overlapping infections and co‐occurrence may increase the number of patients requiring intensive care and mechanical ventilation. In regions such as Valle del Cauca, intensified preparation for such scenarios should be pondered, and further studies should be performed to address this critical issue in a timely matter. This article is protected by copyright. All rights reserved. Coronavirus Disease 2019 , caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has rapidly spread throughout Latin America. 1 However, other emerging and reemerging diseases already present in Colombia before the pandemic wave arrived should not be overlooked by regional public health authorities. Failure to continue surveillance programs on such concurrent diseases and relocating excessive efforts and resources onto COVID-19 containment may severely impact the public health system as a result of healthcare downturn. 2 Many examples of concurrent infectious diseases with epidemic potential have been reported as a consequence of the resurgence and spillover of previously controlled vector-borne and vaccine-preventable diseases in Venezuela: 3 dengue, malaria, measles, diphtheria, among others, reemerged in the country to later spread through the region due to forced migration during an unprecedented humanitarian crisis. In this context, we believe that dengue may follow similar trends in Colombia posing a significant threat to public health. [4] [5] [6] [7] [8] [9] Over the course of 2019, the Americas collectively reported 3,139,335 cases of dengue virus (DENV) infection, 4 and, as expected, in 2020, dengue fever and COVID-19 have now started to overlap within the region and other continents. 10 This article is protected by copyright. All rights reserved. We performed an observational, ecological study analyzing the current epidemiological trends for both diseases in Colombia at a district and departmental levels (primary administrative level), as well as nation-wide, by epidemiological weeks (EW) using publicly available official data. Dengue and COVID-19 data were obtained from the public epidemiological surveillance system online (www.ins.gov.co), for the study period. We included all COVID-19 cases reported and confirmed by the Colombian Ministry of Health using SARS-CoV-2 RT-PCR detection. Over the last five years It is expected that the total number of COVID-19 cases for 2020 will outnumber those of dengue. As dengue fever endemicity has been sustained in Colombia for decades (Figure 1 ), 11 data on endemic corridors for 2020 is widely available. For the first 12 EW, dengue reached epidemic proportions; and between EW 13 to 22, dengue cases have remained in the alert zone---between the geometric median and the 95%CI upper limit. Analysis at a departmental level reveals more interesting data. In some regions such as Valle Colombia has performed 319,779 SARS-CoV-2 RT-PCR tests to date, but the numbers may drastically vary depending on the department, ranging from 165 in Vichada to 98,661 tests performed in Bogota (Figure 2 ). We propose different scenarios that might explain the phenomena observed at a departmental with enalapril reduced the percentage of macrophages expressing DENV2 antigens in vivo, suggesting a decrease in viral entry and a potential role of Ang II in dengue virus infection. 15 The mechanism by which Ang II affects dengue viral entry remains unclear; however, viral interaction with AT1 or phagocytic receptors could be involved. 15 The concurrence of COVID-19 and dengue fever should be carefully reported and followed with enhanced surveillance. The impact of COVID-19 containment measures on other infectious diseases is still unknown. However, a rebound peak of dengue might be observed after containment finishes due to the replenishment of susceptible individuals with low exposure to the infection. 16 Public health officials need to be aware of the possibility of coinfection, as it has already been reported that SARS-CoV-2 can coexist with other viruses (e.g., Influenza, Parainfluenza) within the same host. [17] [18] [19] Coinfections between dengue and influenza have also been reported. 20 Besides dengue, other neglected tropical diseases should be considered in specific areas; such is the case of malaria and acute Chagas disease, which are also febrile conditions. 21 Initial discrimination of dengue fever from COVID-19 could become challenging given some common clinical and laboratory findings, including fever, malaise, myalgia, headaches, and weakness. 22 In dengue-endemic areas, there is also a reported risk of false-positive dengue virus testing using serological approaches that have later resulted in a delayed molecular diagnosis of SARS-CoV-2 infection, which may result in an increased risk of poor clinical outcomes as both viruses might lead to severe complications, mainly via cytokine storm in lung tissue caused by macrophage hyperactivation. 5, 23 Fortunately, the diagnosis of SARS-CoV-2 infection in Colombia so far is made exclusively by RT-PCR, but this should be considered if the use of serological tests for COVID-19 becomes widespread. Recently, Brazilian researchers have modeled hypothetical scenarios for dengue fever and COVID-19 co-emergence. 22 However, no conclusive data on disease overlapping has been published so far. Intense interventions, especially in certain areas, may help to keep dengue incidence at lower levels. Other arboviral diseases such as Chikungunya and Zika have caused recent epidemics in Colombia, with reported cases of coinfection with dengue virus. 24 COVID-19 in Latin America: The implications of the first confirmed case in Brazil Latin America: Role of primary care The current syndemic in Venezuela: Measles, malaria and more coinfections coupled with a breakdown of social and healthcare infrastructure. Quo vadis? Covert COVID-19 and false-positive dengue serology in Singapore Dengue in Honduras and the Americas: The epidemics are back COVID-19 and dengue, coepidemics in Ecuador and other countries in Latin America: Pushing strained health care systems over the edge Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents COVID-19 and dengue virus coepidemics in Pakistan: A dangerous combination for overburdened healthcare system Potential impact of climatic variability on the epidemiology of dengue in Risaralda, Colombia Coinfections of the Respiratory Tract: Viral Competition for Resources COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options Losartan and enalapril decrease viral absorption and interleukin 1 beta production by macrophages in an experimental dengue virus infection Can we contain the COVID-19 outbreak with the same measures as for SARS? Co-infection with SARS-CoV-2 and influenza A virus Coinfection with SARS-COV-2 and Parainfluenza in a young adult patient with pneumonia: Case Report Are we now observing an increasing number of coinfections between SARS-CoV-2 and other respiratory pathogens Severe coinfections of dengue and pandemic influenza A H1N1 viruses Report: Diagnosis of Novel Coronavirus Disease (COVID-19) versus Tropical Diseases in Pakistan COVID-19 and dengue fever: A dangerous combination for the health system in Brazil Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages Dengue, chikungunya and Zika co-infection in a patient from Colombia Will the Colombian intensive care units collapse due to the COVID-19 pandemic Relationship between Dengue and COVID-19 by departments. The map inserted indicates the places with a higher occurrence of Dengue and COVID-19 cases from the graph. C. Number of COVID-19 tests (RT-PCR for SARS-CoV-2) applied by departments.